Leading American, German chemists converge to share research, vision

A group of 70 American and German chemists, age 40 or younger, will meet later this month in Durham, N.H. to share scientific ideas and results in leading areas of chemical research, including biomolecular engineering and bioinspired materials, molecular electronics, nanooptics and frontiers in synthesis.

The German-American Frontiers of Chemistry Symposium to be held August 23-25 at the New England Center in Durham is sponsored by the American Chemical Society, the worlds largest scientific society, and the German Chemical Society (Gesellschaft Deutscher Chemiker). Participants were selected by the symposiums organizing committees.

The symposium, which draws elite chemists from academia and industry in each country, provides a forum for chemists to learn about cutting-edge research in each others countries and in areas beyond their own specialties.

Speakers at the symposium will include: Eli Pearce, Ph.D., ACS president and university research professor at Polytechnic University in Brooklyn, N.Y; Gesellschaft Deutscher Chemiker Secretary General Heindirk tom Dieck, Ph.D.; and George Atkinson, Ph.D., University of Arizona professor and Senior Fellow for Science, Technology and Diplomacy at the U.S. Department of State.

The inaugural Frontiers of Chemistry Symposium was held in 2000 in Munich, Germany.

German-American Frontiers of Chemistry Symposium

New England Center in Durham, N.H

Aug. 23-25, 2002


Contact: Tiffany Steele McAvoy
American Chemical Society

Page: 1

Related medicine news :

1. Leading researchers in allergic disease to gather for 2005 AAAAI Annual Meeting
2. Leading tobacco manufacturer conceals links to tobacco research facility
3. Leading MRSA experts address emergence of superbug
4. Leading causes of blindness for blacks and whites different
5. Leading cancer doctor calls for new guidelines to control early reporting from clinical trials
6. Leading AIDS experts criticize US-sponsored HIV vaccine trial in Thailand
7. Leading the way in novel anti-cancer research
8. Leading anti-cancer factions strengthen bonds
9. Leading NIH-funded medical schools agree on guidelines that would strenghten conflict of interest policies
10. Biochemical Marker Targets Brain Injury Leading To Movement Problems After Stroke
11. New Model Shows How To Eradicate Worlds Leading Infectious Cause Of Blindness

Post Your Comments:

(Date:12/1/2015)... ... 2015 , ... For the millions of people who use ... launched the VaPro Plus Pocket™ touch free hydrophilic intermittent catheter. “Hollister Continence Care ... portfolio,” said Michael Gresavage, Vice President North America. "We designed our VaPro Plus ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit , ... control over customization, the possibilities are truly endless, all with a click of a ... position, vertical flip, horizontal flip, depth of field and more, all within Final Cut ...
(Date:11/30/2015)... ... November 30, 2015 , ... Third ... today that it has officially launched a sleek, mobile-ready and user-centric redesigned website. ... company’s new website clearly outlines the benefits that its SEO services provide to ...
(Date:11/30/2015)... ... , ... The National Association of Professional Women (NAPW) honors ... Circle. She is recognized with this prestigious distinction for leadership in estate sales and ... than 850,000 members and over 200 operating Local Chapters. , “I’m pleased to welcome ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , December 1, 2015 ... Injectables, Topical Contraceptives, Male Condoms, Female Condoms, ... Rings, Contraceptive Diaphragms, Contraceptive Sponges, Non-Surgical Permanent ... Share, Growth, Trends and Forecast 2014 - ... Market Research (TMR).The report states that the ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
(Date:12/1/2015)... , Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), ... commercialization of therapies for cardiovascular conditions via the inhalation ... business in Australia . InCarda is ... Australia in the first half ... and medical centers in Adelaide ...
Breaking Medicine Technology:
Cached News: